Revolution Medicines to Present Clinical Data from RAS(ON) Inhibitor Combination Trials in Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. GOOG
6. CSX
7. KNX
8. AMD
9. IBM
10. LVS

Go back to Revolution Medicines to Present Clinical Data from RAS(ON) Inhibitor Combination Trials in Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
(NASDAQ: RVMD) Delayed: 188.35 +5.32 (2.91%)
Previous Close $183.03    52 Week High $ 
Open $182.61    52 Week Low $ 
Day High $193.53    P/E N/A 
Day Low $180.00    EPS $ 
Volume 1,400,548